WELLINGTON MANAGEMENT GROUP LLP

Position in EYPT — EyePoint, Inc.

CIK 902219 Boston, MA

Position in EYPT

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$3,337,760

-$100,634 QoQ

Shares Held

258,942

+37.6% QoQ

Ownership

0.309%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Jun 2024

8 quarters on record

Voting authority Sole 0.ToString("F0")% Shared 73.2299124900557.ToString("F0")% None 26.77008750994431.ToString("F0")%

Healthcare · as of Mar 31, 2026

WELLINGTON MANAGEMENT GROUP LLP holds $14,418,547,095 across 180 Biotechnology names. EYPT ranks #89 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	3,212,589	$1,434,549,489
2	REGN	Regeneron Pharmaceuticals, Inc.	1,837,459	$1,419,694,318
3	ARGX	Argenx SE	1,021,457	$745,918,971
4	ALNY	Alnylam Pharmaceuticals, Inc.	1,935,925	$640,539,501
5	RVMD	Revolution Medicines, Inc.	6,027,819	$586,205,394
6	CYTK	Cytokinetics Inc	8,009,489	$527,905,416
7	IONS	Ionis Pharmaceuticals Inc	6,391,816	$479,961,458
8	ASND	Ascendis Pharma A/S	1,757,633	$402,023,391

8 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$3,337,760	258,942	+37.6%	Shares	Defined	2026-05-15
2025-12-31	$3,438,394	188,199	-12.6%	Shares	Defined	2026-02-17
2025-09-30	$3,068,007	215,450	-18.7%	Shares	Defined	2025-11-14
2025-06-30	$2,494,674	265,109	+13.7%	Shares	Defined	2025-08-14
2025-03-31	$1,264,111	233,231	+31.5%	Shares	Defined	2025-05-13
2024-12-31	$1,321,003	177,316	+3.2%	Shares	Defined	2025-02-12
2024-09-30	$1,372,393	171,764	+59.4%	Shares	Defined	2024-11-14
2024-06-30	$937,476	107,756	—	Shares	Defined	2024-08-14
No filing history on record for this holder in this stock.